1World Health Organizition and Health Action In- ternational.Measuring medicine price, availability, af- fordability and price component (2th edition).Geneva: WHO,2008.
4WHO, HAI. Medicine prices : a new approach to measure- ment. Working draft for field-testing and revision[DB/OL ]. [2010-03-01].http://www.haiweb.org/medicinepriees/ma- nual/manuals/MedicinePrices.pdf.
5MSH. International Drug Price Indicator Guide[DB/OL ]. [2012-03-08]. http://apps.who.inl/medicinedocs/fr/m/ab- stract/Js 19968en/.
8Shanti M, Keiko F, Alexandr C, et al. The availability and affordability of selected essential medicines for chron- ic diseases in six low- and middle-income countries[J]. Bulletin of the World Health Organization, 2007,85 (4) : 279.
9HA1. Medicine prices, Availability, Affordability & Price Components[EB/O L ]. [2013-02-02].http://www.haiweb. org/medicineprices.
10Hao Y, Hassan HD, Minmin Z, et al. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China[J]. Health Policy And Planning, 2010,25 (3) :219.